Albemarle (ALB)
(Delayed Data from NYSE)
$100.84 USD
+0.91 (0.91%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $100.79 -0.05 (-0.05%) 7:58 PM ET
5-Strong Sell of 5 5
F Value B Growth F Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$100.84 USD
+0.91 (0.91%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $100.79 -0.05 (-0.05%) 7:58 PM ET
5-Strong Sell of 5 5
F Value B Growth F Momentum D VGM
Zacks News
Albemarle (ALB) Shares Up 11% in 3 Months: What's Driving It?
by Zacks Equity Research
Albemarle (ALB) gains on strong lithium demand and actions to boost its global lithium capacity.
Albemarle (ALB) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Albemarle (ALB) closed at $226.80, marking a -0.9% move from the previous day.
Here is What to Know Beyond Why Albemarle Corporation (ALB) is a Trending Stock
by Zacks Equity Research
Albemarle (ALB) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Albemarle (ALB) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Albemarle (ALB) closed the most recent trading day at $219.62, moving +0.37% from the previous trading session.
Albemarle (ALB) Up 11.3% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Albemarle (ALB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Is Trending Stock Albemarle Corporation (ALB) a Buy Now?
by Zacks Equity Research
Zacks.com users have recently been watching Albemarle (ALB) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Here's Why You Should Hold Onto Albemarle (ALB) Stock for Now
by Zacks Equity Research
While Albemarle (ALB) faces headwinds from high input costs, it benefits from higher lithium volumes and actions to boost its global lithium capacity.
Albemarle (ALB) to Supply Battery-Grade Lithium Hydroxide to Ford
by Zacks Equity Research
In addition to the supply of lithium hydroxide, Albemarle (ALB) and Ford plan to explore collaborations to build a closed-loop solution for lithium-ion battery recycling.
Ford (F) Sets Forth Plan to Boost EV Production Profitably
by Zacks Equity Research
Ford (F) targets to achieve an 8% EBIT margin on its EV units and an EV production run rate of 2 million by 2026. It also announces new deals for the supply of lithium products.
Albemarle Corporation (ALB) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Albemarle (ALB) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Insiders Are Diving Into These 3 Stocks
by Derek Lewis
When an insider buys, it can deliver a positive message to shareholders, indicating that they're confident in the long-term picture of the business.
Wall Street Analysts See Albemarle (ALB) as a Buy: Should You Invest?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Albemarle (ALB) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
Albemarle Corporation (ALB) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Albemarle (ALB) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Albemarle's (ALB) Q1 Earnings Top Estimates, Revenues Miss
by Zacks Equity Research
Albemarle (ALB) gains on higher lithium pricing and increased volumes in the first quarter.
Albemarle (ALB) Surpasses Q1 Earnings Estimates
by Zacks Equity Research
Albemarle (ALB) delivered earnings and revenue surprises of 48.92% and 5.71%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Albemarle (ALB) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Albemarle (ALB) closed the most recent trading day at $185.46, moving -0.29% from the previous trading session.
Analysts Estimate Huntsman (HUN) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Huntsman (HUN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Albemarle (ALB) to Post Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Albemarle (ALB) is likely to have benefited from higher lithium prices and volumes and its cost-reduction actions in the first quarter amid headwinds from higher input costs.
Chemours (CC) Surpasses Q1 Earnings Estimates
by Zacks Equity Research
Chemours (CC) delivered earnings and revenue surprises of 58.06% and 0.87%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
DuPont (DD) Gears Up for Q1 Earnings: What's in the Cards?
by Zacks Equity Research
DuPont (DD) is expected to have gained from the strength in water and general industrial and its pricing and productivity actions in the first quarter.
Livent (LTHM) to Report Q1 Earnings: What's in the Offing?
by Zacks Equity Research
Livent's (LTHM) Q1 results are expected to reflect the benefits of higher realized pricing and strong lithium demand.
4 Chemical Stocks Poised to Outshine Q1 Earnings Estimates
by Anindya Barman
While softer demand in certain end markets is likely to be a drag, Albemarle (ALB), DuPont (DD), Axalta (AXTA) and LyondellBasell (LYB) are likely to have benefited from cost and pricing actions in Q1.
Albemarle (ALB) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Albemarle (ALB) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CF Industries (CF) to Report Q1 Earnings: What's in Store?
by Zacks Equity Research
CF Industries' (CF) first-quarter performance will likely reflect the impacts of softer nitrogen prices and high natural gas costs.
Company News for Apr 25, 2023
by Zacks Equity Research
Companies in The News Are: FOXA, ALB, TSLA, AAPL.